| FDA New, GMP Do Clinical Phase II, III Intermediates GMP Custom synthesis, Full Document R&D Center: 8000 sq, More than 100 hoods Pilot Plant: 20000sq, 40 reactors from 5-200L Manufacturing Site: 800000sq, 40 reactors from 100-5000L Web: www.eosmedchem.com Email: info@eosmedchem.com; eosmedchem@gmail.com This is my R&D youtube: https://youtu.be/r5cJdXKNXHk |
| Semapimod Mesylate, 352513-83-8, Semapimod Mesylate Intermediate 618-88-2, stock 523.6g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
| Semapimod Mesylate, 352513-83-8, Semapimod Mesylate Intermediate 13438-30-7, stock 297.2g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
| Semapimod Mesylate, 352513-83-8, Semapimod Mesylate Intermediate 87533-54-8, stock 751g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| Semapimod Mesylate, 352513-83-8, Semapimod Mesylate Intermediate 87533-49-1, stock 182.2g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| Semapimod Mesylate, 352513-83-8, Semapimod Mesylate Intermediate 111-19-3, stock 858.1g, white powder, assay by HPLC 99.5%, HNMR, LCMS we supply. |
| Semapimod Mesylate, 352513-83-8, Semapimod Mesylate Intermediate 169765-28-0, stock 718.5g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| Semapimod Mesylate, 352513-83-8, Semapimod Mesylate Intermediate 1937-19-5, stock 388.5g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
| Semapimod Mesylate, 352513-83-8, Semapimod Mesylate Intermediate 352513-83-8, stock 867.7g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
